Seek Returns logo

EW vs. VEEV: A Head-to-Head Stock Comparison

Updated on

Here’s a clear look at EW and VEEV, comparing key factors like historical performance, profitability, financial strength, growth, dividend, and valuation.

Company Profile

SymbolEWVEEV
Company NameEdwards Lifesciences CorporationVeeva Systems Inc.
CountryUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS IndustryHealth Care Equipment & SuppliesHealth Care Technology
Market Capitalization44.80 billion USD48.07 billion USD
ExchangeNYSENYSE
Listing DateMarch 27, 2000October 16, 2013
Security TypeCommon StockCommon Stock

Historical Performance

This chart compares the performance of EW and VEEV by tracking the growth of an initial $10,000 investment in each. Use the tabs to select the desired time period. Data is adjusted for dividends and splits.

EW vs. VEEV: Growth of a $10,000 investment over the past one year.

Historical Performance at a Glance

SymbolEWVEEV
5-Day Price Return4.17%7.19%
13-Week Price Return-0.56%3.45%
26-Week Price Return9.40%26.44%
52-Week Price Return16.81%41.29%
Month-to-Date Return-4.39%10.66%
Year-to-Date Return5.05%41.69%
10-Day Avg. Volume5.34M1.29M
3-Month Avg. Volume4.28M1.44M
3-Month Volatility20.02%26.99%
Beta1.020.98

Profitability

Return on Equity (TTM)

EW

41.25%

Health Care Equipment & Supplies Industry

Max
29.93%
Q3
16.99%
Median
9.28%
Q1
5.10%
Min
-12.52%

EW’s Return on Equity of 41.25% is exceptionally high, placing it well beyond the typical range for the Health Care Equipment & Supplies industry. This demonstrates a superior ability to generate profit from shareholder investments, though it could also be inflated by high financial leverage.

VEEV

13.40%

Health Care Technology Industry

Max
48.09%
Q3
41.80%
Median
18.17%
Q1
11.64%
Min
11.05%

VEEV’s Return on Equity of 13.40% is on par with the norm for the Health Care Technology industry, indicating its profitability relative to shareholder equity is typical for the sector.

EW vs. VEEV: A comparison of their Return on Equity (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Net Profit Margin (TTM)

EW

72.96%

Health Care Equipment & Supplies Industry

Max
24.41%
Q3
13.71%
Median
10.08%
Q1
5.96%
Min
-5.58%

EW’s Net Profit Margin of 72.96% is exceptionally high, placing it well beyond the typical range for the Health Care Equipment & Supplies industry. This demonstrates outstanding operational efficiency and a strong competitive advantage in converting revenue into profit.

VEEV

27.29%

Health Care Technology Industry

Max
52.24%
Q3
49.15%
Median
33.59%
Q1
16.86%
Min
13.38%

VEEV’s Net Profit Margin of 27.29% is aligned with the median group of its peers in the Health Care Technology industry. This indicates its ability to convert revenue into profit is typical for the sector.

EW vs. VEEV: A comparison of their Net Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Operating Profit Margin (TTM)

EW

25.01%

Health Care Equipment & Supplies Industry

Max
31.09%
Q3
18.11%
Median
15.07%
Q1
8.48%
Min
-0.28%

An Operating Profit Margin of 25.01% places EW in the upper quartile for the Health Care Equipment & Supplies industry. This signals a strong ability to translate revenue into operating profit, outperforming most of its competitors in core business efficiency.

VEEV

26.93%

Health Care Technology Industry

Max
74.05%
Q3
65.56%
Median
33.50%
Q1
22.83%
Min
21.46%

VEEV’s Operating Profit Margin of 26.93% is around the midpoint for the Health Care Technology industry, indicating that its efficiency in managing core business operations is typical for the sector.

EW vs. VEEV: A comparison of their Operating Profit Margin (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Profitability at a Glance

SymbolEWVEEV
Return on Equity (TTM)41.25%13.40%
Return on Assets (TTM)31.58%10.96%
Net Profit Margin (TTM)72.96%27.29%
Operating Profit Margin (TTM)25.01%26.93%
Gross Profit Margin (TTM)78.87%75.59%

Financial Strength

Current Ratio (MRQ)

EW

4.68

Health Care Equipment & Supplies Industry

Max
5.19
Q3
3.00
Median
2.13
Q1
1.44
Min
0.86

EW’s Current Ratio of 4.68 is in the upper quartile for the Health Care Equipment & Supplies industry. This signifies a strong liquidity position, suggesting the company is well-equipped to cover its immediate liabilities compared to its peers.

VEEV

5.57

Health Care Technology Industry

Max
6.49
Q3
6.49
Median
6.02
Q1
3.62
Min
2.96

VEEV’s Current Ratio of 5.57 aligns with the median group of the Health Care Technology industry, indicating that its short-term liquidity is in line with its sector peers.

EW vs. VEEV: A comparison of their Current Ratio (MRQ) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Debt-to-Equity Ratio (MRQ)

EW

0.06

Health Care Equipment & Supplies Industry

Max
1.61
Q3
0.76
Median
0.45
Q1
0.14
Min
0.00

Falling into the lower quartile for the Health Care Equipment & Supplies industry, EW’s Debt-to-Equity Ratio of 0.06 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

VEEV

0.00

Health Care Technology Industry

Max
0.14
Q3
0.10
Median
0.01
Q1
0.00
Min
0.00

Falling into the lower quartile for the Health Care Technology industry, VEEV’s Debt-to-Equity Ratio of 0.00 points to a conservative financing strategy. This results in lower financial risk but potentially limits strategic investments compared to more leveraged competitors.

EW vs. VEEV: A comparison of their Debt-to-Equity Ratio (MRQ) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Interest Coverage Ratio (TTM)

EW

3.15

Health Care Equipment & Supplies Industry

Max
56.35
Q3
25.56
Median
9.60
Q1
3.78
Min
-26.49

In the lower quartile for the Health Care Equipment & Supplies industry, EW’s Interest Coverage Ratio of 3.15 indicates a tighter cushion for servicing debt, suggesting less financial flexibility than many of its competitors.

VEEV

169.00

Health Care Technology Industry

Max
224.12
Q3
224.12
Median
219.00
Q1
219.00
Min
219.00

VEEV’s Interest Coverage Ratio of 169.00 is below the typical range for the Health Care Technology industry. This suggests a weaker ability to meet debt obligations compared to its peers and may indicate a higher level of financial risk.

EW vs. VEEV: A comparison of their Interest Coverage Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Financial Strength at a Glance

SymbolEWVEEV
Current Ratio (MRQ)4.685.57
Quick Ratio (MRQ)3.795.48
Debt-to-Equity Ratio (MRQ)0.060.00
Interest Coverage Ratio (TTM)3.15169.00

Growth

Revenue Growth

EW vs. VEEV: A side-by-side comparison of their Revenue Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

EPS Growth

EW vs. VEEV: A side-by-side comparison of their EPS Growth for the MRQ (YoY), TTM (YoY), 3-Year CAGR, and 5-Year CAGR periods.

Dividend

Dividend Yield (TTM)

EW

0.00%

Health Care Equipment & Supplies Industry

Max
4.15%
Q3
1.76%
Median
0.79%
Q1
0.00%
Min
0.00%

EW currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

VEEV

0.00%

Health Care Technology Industry

Max
0.89%
Q3
0.70%
Median
0.15%
Q1
0.04%
Min
0.00%

VEEV currently does not pay a dividend, resulting in a yield of 0%. This is a common strategy for growth-focused companies that prioritize reinvesting earnings, though it may be less typical in mature, income-oriented sectors.

EW vs. VEEV: A comparison of their Dividend Yield (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Dividend Payout Ratio (TTM)

EW

0.00%

Health Care Equipment & Supplies Industry

Max
160.00%
Q3
66.60%
Median
27.49%
Q1
0.00%
Min
0.00%

EW has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

VEEV

0.00%

Health Care Technology Industry

Max
101.92%
Q3
87.10%
Median
42.63%
Q1
10.66%
Min
0.00%

VEEV has a Dividend Payout Ratio of 0%, indicating it does not currently pay a dividend. This is a common strategy for growth-oriented companies that reinvest all profits back into the business.

EW vs. VEEV: A comparison of their Dividend Payout Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Dividend at a Glance

SymbolEWVEEV
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

Price-to-Earnings Ratio (TTM)

EW

10.61

Health Care Equipment & Supplies Industry

Max
67.29
Q3
47.01
Median
30.94
Q1
23.91
Min
10.79

EW’s P/E Ratio of 10.61 is below the typical range for the Health Care Equipment & Supplies industry. This may indicate that the stock is potentially undervalued, or it could reflect market concerns about the company’s future prospects.

VEEV

59.31

Health Care Technology Industry

Max
280.41
Q3
225.12
Median
59.01
Q1
44.08
Min
39.20

VEEV’s P/E Ratio of 59.31 is within the middle range for the Health Care Technology industry. This suggests its valuation is in line with the sector average, representing neither a significant premium nor a discount compared to its peers.

EW vs. VEEV: A comparison of their Price-to-Earnings Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Price-to-Sales Ratio (TTM)

EW

7.74

Health Care Equipment & Supplies Industry

Max
9.49
Q3
5.41
Median
2.86
Q1
2.07
Min
0.74

EW’s P/S Ratio of 7.74 is in the upper echelon for the Health Care Equipment & Supplies industry. This means the company is valued richly on its revenue stream compared to its peers, suggesting the stock is priced for a high level of future performance.

VEEV

16.18

Health Care Technology Industry

Max
146.49
Q3
115.78
Median
19.83
Q1
7.94
Min
5.25

VEEV’s P/S Ratio of 16.18 aligns with the market consensus for the Health Care Technology industry. This suggests its valuation, based on sales, is seen as standard and is on par with its competitors.

EW vs. VEEV: A comparison of their Price-to-Sales Ratio (TTM) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Price-to-Book Ratio (MRQ)

EW

4.35

Health Care Equipment & Supplies Industry

Max
10.85
Q3
6.56
Median
3.53
Q1
2.36
Min
0.71

EW’s P/B Ratio of 4.35 is within the conventional range for the Health Care Equipment & Supplies industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

VEEV

7.00

Health Care Technology Industry

Max
115.01
Q3
89.07
Median
9.11
Q1
4.04
Min
3.06

VEEV’s P/B Ratio of 7.00 is within the conventional range for the Health Care Technology industry. This shows a balanced market view, where the stock’s price is neither at a significant premium nor a discount to the book value of its peers.

EW vs. VEEV: A comparison of their Price-to-Book Ratio (MRQ) against their respective Health Care Equipment & Supplies and Health Care Technology industry benchmarks.

Valuation at a Glance

SymbolEWVEEV
Price-to-Earnings Ratio (TTM)10.6159.31
Price-to-Sales Ratio (TTM)7.7416.18
Price-to-Book Ratio (MRQ)4.357.00
Price-to-Free Cash Flow Ratio (TTM)57.9236.17